Current Members

Chaochun Wei

Chaochun Wei

Chaochun Wei

Name: Chaochun Wei (未朝春)

Gender: Male

Nationality: China

Place of birth: Anhui province, China

Date of birth: Mar. 12th, 1995

Email: [email protected]

Mail Address: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Xue Yuan Road 38, Beijing 100191, China

Education

2025.08 - : Present Postdoctoral fellow in Medicinal Chemistry, School of Pharmaceutical Sciences, Peking University

2022.09 - 2025.06: Ph.D. Candidate in Biomedicine and Engineering, College of Chemistry and Life Science, Beijing University of Technology

2019.09 - 2022.06: Master in Biomedicine and Engineering, College of Chemistry and Life Science, Beijing University of Technology

2014.09 - 2018.06: Bachelor in Food science and engineering, Guangxi University

Publications

  1. Chaochun Wei, Keli Zong, Hong Yan*, et al. Discovery of novel inhibitors of dengue viral RNA-dependent RNA polymerase by molecular docking, in vitro assay, DFT, and MD simulations [J]. International Journal of Biological Macromolecules, 2025, 305:141328
  2. Chaochun Wei, CuiCui Ji, Hong Yan*, et al. Identification of novel inhibitors targeting EGFR L858R/T790M/C797S against NSCLC by molecular docking, MD simulation, and DFT approaches [J]. Journal of Molecular Graphics and Modelling, 2025, 138:109052
  3. Chaochun Wei, Keli Zong, Hong Yan*, et al. Identification of novel non-covalent Mpro inhibitors against SARS-CoV-2 by the computational and experimental approaches [J]. Journal of Molecular Graphics and Modelling, 2025, 141:109151
  4. Chaochun Wei, Haolin Zhang, Hong Yan*, et al. 4D-QSAR, ADMET properties, and molecular dynamics simulations for designing N-substituted urea/thioureas as human glutaminyl cyclase inhibitors [J]. Computational Biology and Chemistry, 2024, 112:108131
  5. Chaochun Wei, Liying Zhou, Hong Yan*, et al. Design, synthesis and anticancer evaluation of N6-hydrazone purine derivatives with potential antiplatelet aggregation activity [J]. Chemical Biology & Drug Design, 2022, 101:568–580